Cell Therapy

The cell therapy oncology market is expected to reach $30bn by 2030. (Image: iStock)

GE acquires stem cell supplier Biosafe

By Melissa Fassbender

GE Health has acquired Biosafe in a move that it says will enable production of cell and gene therapies on an industrialized scale.

Best before... Image: StanleyD

Cell Therapy Manufacturing & Gene Therapy Congress - Brussels, Belgium

Short shelf-life poses problems for cell therapy makers, Chiesi

By Dan Stanton

The shelf life of a cell therapy product is crucial in determining a firm’s manufacturing strategy according to the makers of the first approved stem-cell based drug.

Survey finds solid base for UK early phase cell therapy manufacturing

Survey finds solid base for early phase cell therapy manufacturing in UK

By Zachary Brennan

The UK manufacturing sector covers all of its bases in terms of the current cell therapy manufacturing requirements and includes “a strong manufacturing base” to bring early phase academic research into the clinic, according to a survey conducted by Cell...